The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
May. 05, 2020
Filed:
Apr. 12, 2017
Applicant:
Arturo Solis Herrera, Aguascalientes, MX;
Inventor:
Arturo Solis Herrera, Aguascalientes, MX;
Assignee:
Other;
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/44 (2006.01); A61K 31/60 (2006.01); A61K 31/4439 (2006.01); A61K 9/00 (2006.01); A61K 9/08 (2006.01); A61K 47/38 (2006.01); A61P 11/02 (2006.01); A61K 9/12 (2006.01); A61K 47/12 (2006.01); A61N 5/06 (2006.01);
U.S. Cl.
CPC ...
A61K 31/4439 (2013.01); A61K 9/0043 (2013.01); A61K 9/08 (2013.01); A61K 9/12 (2013.01); A61K 47/38 (2013.01); A61P 11/02 (2018.01); A61K 47/12 (2013.01); A61N 5/0603 (2013.01); A61N 2005/0607 (2013.01);
Abstract
Methods of treating and preventing conditions of a nasal or paranasal mucous membrane are described. The methods include administering a pharmaceutical composition including a nicotinic acetylcholine receptor (nAChR) agonist, such as (S)-(1-methyl-2-pyrrolidinyl)-pyridine, or a pharmaceutically acceptable salt, analog, precursor or derivative thereof. The methods can be used to treat a wide variety of conditions of the nasal or paranasal mucous membrane, such as nasal congestion and nose bleeds.